Peyronies Disease Treatment Market Demonstrates Strong Growth Potential With 10.5% CAGR Forecast

Peyronies Disease Treatment Market

The Business Research Company

The Business Research Company's Peyronies Disease Treatment Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, September 10, 2026 /EINPresswire.com/ -- "The market for Peyronie’s disease treatments has seen significant expansion in recent years, driven by growing awareness and advances in medical therapies. This specialized sector is rapidly evolving as new treatment options and broader healthcare access increase patient opportunities. Let’s explore the current market size, key growth drivers, regional trends, and future outlook in this important field.

Peyronies Disease Treatment Market Size and Growth Trajectory
The value of the Peyronie’s disease treatment market has surged notably, with an expected rise from $1.05 billion in 2025 to $1.16 billion in 2026, marking a compound annual growth rate (CAGR) of 10.3%. This upward trend during the past years is largely due to the increasing occurrence of Peyronie’s disease coupled with related erectile dysfunction cases. Growing public awareness about male sexual health disorders, limited availability of early-stage non-surgical treatments, a rise in surgical corrective procedures for severe instances, and expansion of specialized urology care infrastructure have all contributed to this growth.

Download a free sample of the peyronies disease treatment market report:
https://thebusinessresearchcompany.com/sample_request?id=92791780&type=smp&name=Peyronies%20Disease%20Treatment%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Sep_PR

Looking ahead, the market is projected to expand even more rapidly, reaching $1.73 billion by 2030, with a CAGR of 10.5%. Factors driving this forecast include the development of innovative antifibrotic medications and biologic therapies, heightened demand for non-invasive and outpatient treatments, and ongoing clinical research focused on regenerative medicine for penile tissue repair. Additionally, increasing patient preference for combination therapies, improved healthcare access, and reimbursement policies supporting men’s health treatments will propel the market forward. Notable trends expected to shape the industry involve the growth of oral pharmacological therapies, broader use of collagenase injections to reduce plaques, rising adoption of penile traction devices to correct curvature, greater utilization of low-intensity shockwave therapy for pain and fibrosis relief, and a shift toward minimally invasive surgical options combined with multimodal treatment approaches.

Understanding Peyronie’s Disease Treatment and Its Objectives
Peyronie’s disease treatment encompasses various medical and therapeutic strategies designed to address the fibrous scar tissue buildup inside the penis. This condition often results in penile curvature, pain, and functional difficulties. Treatment aims to minimize plaque formation, improve the curvature, alleviate discomfort, and restore sexual function through pharmaceutical agents, surgical interventions, and non-surgical methods. The goal is to enhance patient outcomes by employing specialized healthcare procedures, therapeutic devices, and clinical management solutions tailored to individual needs.

View the full peyronies disease treatment market report:
https://www.thebusinessresearchcompany.com/report/peyronies-disease-treatment-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Sep_PR

How Increased Attention to Men’s Health Supports Market Expansion
One of the primary forces fueling growth in the Peyronie’s disease treatment market is the rising global focus on men’s health. This area covers the physical, mental, and reproductive well-being of males, along with the prevention, diagnosis, and treatment of conditions predominantly affecting men. Enhanced awareness of male-specific illnesses has led to earlier detection, better education, and improved access to targeted healthcare services. This growing emphasis encourages men to seek medical advice for urological issues more readily, resulting in increased adoption of specialized therapies and improved health outcomes. For example, in July 2025, the Local Government Association in the UK reported that over 2.74 million people visited sexual health clinics in England during 2023, with men accounting for more than 60 percent of all new sexually transmitted infection diagnoses. Such data illustrates how attention to men’s health directly boosts demand and advances in treatment for Peyronie’s disease.

Regional Highlights in Peyronies Disease Treatment Market Growth
In 2025, North America was the dominant region in the Peyronie’s disease treatment market. However, the Asia-Pacific region is anticipated to experience the fastest growth throughout the forecast period. The comprehensive market report covers multiple geographies including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a global perspective on emerging opportunities and regional dynamics shaping this market.

What’s new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X